Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Traditional Chinese Medicine, Western Medicine and Medical Devices	4.22B	4.24B	3.88B	3.43B	3.41B
Health Food and Food	500.27M	437.48M	502.79M	324.58M	184.23M
Property Leasing and Sales and Others	532.62M	510.55M	494.89M	421.95M	560.99M
Total	5.25B	5.19B	4.87B	4.18B	4.15B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	5.25B	5.19B	4.87B	4.18B	4.15B
Total	5.25B	5.19B	4.87B	4.18B	4.15B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error